Biotech / Medical
Indications -- obesity/erectile dysfunction
An SI Board Since February 2001
Posts SubjectMarks Bans
386 31 0
Emcee:  scaram(o)uche Type:  Moderated

Subject intro modified -- post rimonabant disaster, which was predicted here at S.I. -- to include anything and everything related to cannabinoids and their receptors.....

indication-specific file folder for obesity and/or erectile dysfunction

This thread is still devoted to obesity and ED, but it's also become a parking lot for cannabinoid-related research.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
386Sci Rep. 2016 Sep 19;6:33302. doi: 10.1038/srep33302. Human CB1 Receptor Isoforscaram(o)uche-September 27
385Pain. 2016 Aug 16. [Epub ahead of print] N-palmitoylethanolamide in the anterioscaram(o)uche-September 21
384Childs Nerv Syst. 2016 Sep 9. [Epub ahead of print] Spontaneous involution of pscaram(o)uche-September 12
383Genes (Basel). 2016 Aug 31;7(9). pii: E56. doi: 10.3390/genes7090056. Possible scaram(o)uche-September 8
382Proc Natl Acad Sci U S A. 2016 Aug 15. pii: 201525066. [Epub ahead of print] Pescaram(o)uche-August 18
381Beloranib dropped, zfgn to focus on backup. Don't hold breath.scaram(o)uche-July 20 schizophreniabulletin.oxfordjournals.oscaram(o)uche-March 16
379Eur J Pharmacol. 2016 Feb 16. pii: S0014-2999(16)30069-3. doi: 10.1016/j.ejphar.scaram(o)uche-February 22
378J Pharmacol Exp Ther. 2016 Jan 20. pii: jpet.115.229971. [Epub ahead of print] scaram(o)uche-February 21
377J Med Chem. 2016 Feb 18. [Epub ahead of print] Development and Pharmacological scaram(o)uche-February 21
376CB2 and memory? Something we never hear about...... Neural Plast. 2016;2016:9scaram(o)uche-January 31
375nothing shocking, just parking.... one of my fave cells, MSCs..... Oncotargescaram(o)uche-January 31
374"The" allosteric site? The one studied to date, in any event. Could scaram(o)uche112/15/2015
373Ha! Back on topic. ;-) full text.......... Prevention of Diet-Induced Obesiscaram(o)uche-12/8/2015
372That wasn't meant as an "in your face", hoping you didn't own scaram(o)uche-11/3/2015
370Because everyone shut up! ... or, maybe there was a .....!!!?? You are at age wMiljenko Zuanic-10/16/2015
369>> Efficacy is not an issue. In phase III testing, toxicity will be a big scaram(o)uche-10/16/2015
368How about the exec insiders holding essentially a pittance of shares, having solBiotech Jim110/16/2015
367How's it looking now? Didn't like these guys, first I heard of them, anscaram(o)uche-10/16/2015
366PRAYING that the anecdotal examples become norm, that these observations hold...scaram(o)uche-7/17/2015
365J Leukoc Biol. 2015 Jun 1. pii: jlb.3A0115-030RR. [Epub ahead of print] ?9-Tetrascaram(o)uche-7/14/2015
364Neuropsychopharmacology. 2015 Jun 8. doi: 10.1038/npp.2015.148. [Epub ahead of pscaram(o)uche-6/10/2015
363Yeah, must cut down... <g>nigel bates-5/26/2015
36242% to 39%, falling from two to three cups/day. Not a good trend. I was one ofscaram(o)uche-5/23/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2016 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.